SSRI use during pregnancy and maternal depression – a nationwide birth cohort study on risks to the mother and the newborn

Key Points

• The study aims to investigate the effects of SSRI use during pregnancy on maternal and neonatal health outcomes.
• Analyzed data from a nationwide birth cohort
• Assessed neonatal health outcomes in relation to maternal SSRI use
• Examined risks for gestational diabetes and preterm birth
• Increased symptoms of delayed neonatal adaptation linked to SSRI use
• Potential reduction in the risk of preterm birth observed
• Heightened risk of gestational diabetes identified, suggesting need for further research